Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Pardoll

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
The Journal of Experimental Medicine|November 6, 1998
Potent T cell activation with dimeric peptide-major histocompatibility complex class II ligand: the role of CD4 coreceptorA R Hamad, S M O'Herrin, M S Lebowitz, et al.
Vaccine|March 21, 2001
Therapeutic potential of protein and adjuvant vaccinations on tumour growthC M Gérard, N Baudson, K Kraemer, et al.
The Journal of Experimental Medicine|May 23, 2001
Lack of coreceptor allows survival of chronically stimulated double-negative alpha/beta T cells: implications for autoimmunityA R Hamad, A Srikrishnan, P Mirmonsef, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1993
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunityG Dranoff, E Jaffee, A Lazenby, et al.
Gene Therapy|August 19, 2005
Characterization of HLA-A2-restricted HPV-16 E7-specific CD8(+) T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic miceS Peng, C Trimble, L He, et al.
Cellular Immunology|March 24, 1999
Soluble, high-affinity dimers of T-cell receptors and class II major histocompatibility complexes: biochemical probes for analysis and modulation of immune responsesM S Lebowitz, S M O'Herrin, A R Hamad, et al.
Human Gene Therapy|September 19, 1998
A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinomaE M Jaffee, R Abrams, J Cameron, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The Journal of Experimental Medicine|November 6, 1998
Potent T cell activation with dimeric peptide-major histocompatibility complex class II ligand: the role of CD4 coreceptorA R Hamad, S M O'Herrin, M S Lebowitz, et al.
Vaccine|March 21, 2001
Therapeutic potential of protein and adjuvant vaccinations on tumour growthC M Gérard, N Baudson, K Kraemer, et al.
The Journal of Experimental Medicine|May 23, 2001
Lack of coreceptor allows survival of chronically stimulated double-negative alpha/beta T cells: implications for autoimmunityA R Hamad, A Srikrishnan, P Mirmonsef, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1993
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunityG Dranoff, E Jaffee, A Lazenby, et al.
Gene Therapy|August 19, 2005
Characterization of HLA-A2-restricted HPV-16 E7-specific CD8(+) T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic miceS Peng, C Trimble, L He, et al.
Cellular Immunology|March 24, 1999
Soluble, high-affinity dimers of T-cell receptors and class II major histocompatibility complexes: biochemical probes for analysis and modulation of immune responsesM S Lebowitz, S M O'Herrin, A R Hamad, et al.
Human Gene Therapy|September 19, 1998
A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinomaE M Jaffee, R Abrams, J Cameron, et al.
Pageof 3